BSE filing, NSE: PANACEABIO. Summary written from the filing by ALFA Finder's alert engine.
Panacea Biotec Ltd: key numbers
- Share price
- ₹329.05
- Market cap
- ₹2,015 Cr
- Revenue (annual)
- ₹639.8 Cr
- Net profit (annual)
- ₹-5.37 Cr
- P/E (TTM)
- -283.1×Sector 46.1×
- Promoter holding
- 72.48%+0.00% QoQ
- FII holding
- 2.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panacea Biotec Ltd
All →Panacea Biotec Annual General Meeting
Panacea Biotec held its 42nd Annual General Meeting on September 29, 2026, where members considered and adopted various financial and operational business items.
Panacea Biotec Legal & Regulatory
Panacea Biotec received two Income Tax demand orders totaling ₹4.32 Crore for alleged income misreporting. The company disputes the demand and plans to file an appeal.
- Value
- ₹4.32 Cr
Panacea Biotec Legal & Regulatory
Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.
- Value
- ₹9.82 Cr
Panacea Biotec Other Announcement
Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.
Panacea Biotec Annual General Meeting
Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.
Panacea Biotec Other Announcement
Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.